Work

A preliminary study of the safety, immunogenicity and clinical efficacy of TroVax® given in conjunction with interleukin 2 (IL-2) in the treatment of stage IV renal cell cancer

Year: 2012

Type: dataset

DOI: 10.1186/isrctn83977250

Author: Howard Kaufman

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4229502503

Cites:

Cited by:

Related to: 10